Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that it will release results for its first quarter ended March 31, 2024, after the market close on May 9, 2024.
Earnings Conference Call Information:
| Event: | Natera’s First Quarter 2024 Financial Results |
| Date: | Thursday, May 9, 2024 |
| Time: | 1:30 p.m. PT (4:30 p.m. ET) |
| Live Dial-In: | 1 (888) 770-7321 (Domestic) |
|
| 1 (929) 201-7107 (International) |
| Conference ID: | 7684785 |
| Webcast: | |
| A webcast replay will be available at investor.natera.com. | |
About Natera
Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are supported by more than 200 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California. For more information, visit www.natera.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240501877493/en/
Contacts
Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-405-4709, investor@natera.com
Media: Lesley Bogdanow, VP of Corporate Communications, Natera, Inc., pr@natera.com
Source: Natera, Inc.
View this news release online at:
http://www.businesswire.com/news/home/20240501877493/en
